{"id":"W2545387711","doi":"10.1182/blood.v126.23.4029.4029","title":"Treatment-Free Remission (TFR) Eligibility in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Residual Disease on Long-Term Imatinib (IM) Who Switched to Second-Line Nilotinib (NIL)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McMaster University","funders":"","keywords":"Nilotinib; Medicine; Imatinib; Internal medicine; Imatinib mesylate; Myeloid leukemia; Dasatinib; Tyrosine-kinase inhibitor; Gastroenterology; Surgery; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001743955,0.0001969109,0.000611086,0.0002592331,0.0001944047,0.0003993764,0.0003238481,0.0004135484,0.001771757],"category_scores_gemma":[0.001617262,0.0001214218,0.0008608904,0.0004025768,0.0002305946,0.0005075011,0.000426924,0.0006947397,0.0001873866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000473689,"about_ca_system_score_gemma":0.0005544873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007237614,"about_ca_topic_score_gemma":0.001917362,"domain_scores_codex":[0.9994022,0.0002461298,0.00004739823,0.0001442343,0.00006390989,0.0000962361],"domain_scores_gemma":[0.9988127,0.0003724234,0.0005174623,0.00006524567,0.0000494415,0.00018278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2412541,0.003442025,0.6451921,0.0007300606,0.001339744,0.0004677399,0.0003065398,0.002707662,0.01089633,0.0003050648,0.002918494,0.09044006],"study_design_scores_gemma":[0.01472786,0.05533271,0.9168557,0.00007064204,0.001023207,0.0007857602,0.0001918348,0.003392869,0.002321187,0.0003075233,0.004958034,0.00003264693],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979283,0.00035704,0.0001823902,0.00004968488,0.000005154011,0.0001520382,0.0009334058,0.000008141672,0.0003840176],"genre_scores_gemma":[0.9972258,0.0001145518,0.0003036476,0.00009444956,0.00001252454,0.0002767869,0.001657889,0.000003293157,0.0003111132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001771757,"threshold_uncertainty_score":0.009223044,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02562510594425862,"score_gpt":0.3113910408480349,"score_spread":0.2857659349037763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}